Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing (September 2020)

KE Hanson, AM Caliendo, CA Arias… - Clinical Infectious …, 2024 - academic.oup.com
Background The availability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) serologic testing has rapidly increased. Current assays use a variety of technologies …

Detection of SARS-CoV-2 antibodies: Comparison of enzyme immunoassay, surrogate neutralization and virus neutralization test

T Vilibic-Cavlek, M Bogdanic, E Borko, Z Hruskar… - Antibodies, 2023 - mdpi.com
Background: Since sensitivity and specificity vary widely between tests, SARS-CoV-2
serology results should be interpreted with caution. Methods: The study included serum …

Comprehensive, comparative evaluation of 25 automated SARS-CoV-2 serology assays

W Dimech, S Curley, JJ Cai - Microbiology Spectrum, 2024 - Am Soc Microbiol
The onset of the COVID-19 pandemic resulted in hundreds of in vitro devices coming to
market, facilitated by regulatory authorities allowing “Emergency Use,” without a prior …

[HTML][HTML] The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a …

D Cin, P Soguksu, MM Oren, N Ozgulnar, A Agacfidan… - Viruses, 2024 - mdpi.com
Neutralizing antibodies plays a primary role in protective immunity by preventing severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from entering the cells. Therefore …

[HTML][HTML] The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus …

AR Indrati, E Horian, NS Dewi, N Suraya, MR Tiara… - Diagnostics, 2024 - mdpi.com
COVID-19 infection in high-risk populations is fatal and has a poor prognosis, necessitating
a test to determine the protectiveness of immune response. Antibody testing is necessary to …

[PDF][PDF] IDSA GUIDELINES

MK Hayden, IK El Mikati, KE Hanson, JA Englund… - 2024 - scholar.archive.org
Background: The role of serologic testing for SARS-CoV-2 has evolved during the pandemic
as seroprevalence in global populations has increased. The Infectious Diseases Society of …

[PDF][PDF] Article Not peer-reviewed version

AR Indrati, E Horian, NS Dewi, N Suraya, MR Tiara… - 2024 - preprints.org
COVID-19 infection in high-risk populations is fatal and has a poor prognosis, necessitating
a test to determine the protectiveness of immune response. Antibody testing is necessary to …